Robert W. Cook
Chief Tech/Sci/R&D Officer chez CASTLE BIOSCIENCES, INC.
Profil
Robert W.
Cook is currently the Senior Vice President-Research & Development at Castle Biosciences, Inc. He previously worked at Gen-Probe, Inc. as a Member-Product Transfer Department.
Dr. Cook holds a doctorate degree from Northwestern University and an undergraduate degree from Temple University (Pennsylvania).
Postes actifs de Robert W. Cook
| Sociétés | Poste | Début |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
Anciens postes connus de Robert W. Cook
| Sociétés | Poste | Fin |
|---|---|---|
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Robert W. Cook
| Northwestern University | Doctorate Degree |
| Temple University (Pennsylvania) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
